Recombinant Rat VEGF164

Leinco Technologies
Product Code: LEI-V114
Product Group: Recombinant Proteins
CodeSizePrice
LEI-V114-10ug10 ug£580.00
Quantity:
LEI-V114-50ug50 ug£1,422.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rat
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Further Information

Format:
This recombinant protein was lyophilized from a 0.2 um filtered solution in 35% acetonitrile (CH3CN) and 0.1% trifluoroacetic acid (TFA).
Formulation:
This recombinant protein was lyophilized from a 0.2 um filtered solution in 35% acetonitrile (CH3CN) and 0.1% trifluoroacetic acid (TFA).
Long Description:
Vascular endothelial growth factor (VEGF), a potent proangiogenic cytokine1 is the key signal used by oxygen-hungry cells to promote growth of blood vessels. It binds to specialized receptors on the surfaces of endothelial cells and directs them to build new vessels.2 The alternative splicing of mRNA from a single 8-exon VEGFA gene results in multiple isoforms which are classified by their terminal exon splice site. The classification depends on whether this terminal exon (exon-8) is proximal or distal. VEGF164 refers to the proximal splice site and contains one fewer amino acid than its human ortholog. VEGF are crucial regulators of vascular development during embryogenesis (vasculogenesis) and blood-vessel formation in the adult (angiogenesis). Abnormal VEGF function is associated with inflammatory diseases including atherosclerosis, and hyperthyroidism.3,4,5,6
NCBI Gene:
83785
Purity:
>95% by SDS-PAGE and analyzed by silver stain.
Target:
VEGF 164

References

1. Folkman, J. et al. (2008) FASEB J. 22: 3728 2. Goodsell, DS. et al. (2002) The Oncologist 7: 569 3. Mugishima, H. et al. (2006) J Atheroscler Thromb. 13: 130 4. Claesson-Welsh, L. et al. (2006) Exp Cell Res. 312: 549 5. Claesson-Welsh, L. et al. (1999) Trends Biochem Sci. 28: 488 6. Ellis, LM. et al. (2005) J Clin Oncol. 23: 1011

Related Products

Product NameProduct CodeSupplier 
Recombinant Mouse VEGF 164LEI-V102Leinco Technologies Summary Details